A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces
Clinical trial NCT06151418 · COMPLETED
Trial details
- NCT number
- NCT06151418
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-22
- Primary completion
- 2024-04-23
- Enrollment
- 2313
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.